Genertec Universal Medical Group Company Limited (UMTAF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Genertec Universal Medical Group Company Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
4.73
Strong
WeakModerateStrong
P/B Ratio
0.57
Strong
WeakModerateStrong
Earnings Yield
20.26%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
11.45%
Moderate
WeakModerateStrong
Operating Margin
87.06%
Strong
WeakModerateStrong
Net Profit Margin
15.19%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
16.02%
Strong
WeakModerateStrong
Net Income Growth
7.68%
Weak
WeakModerateStrong
EPS Growth
-5.00%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
3.64
Strong
WeakModerateStrong
Quick Ratio
3.64
Strong
WeakModerateStrong
Asset Turnover
0.17x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
28.28%
Strong
WeakModerateStrong
EV / Free Cash Flow
18.92x
Strong
WeakModerateStrong
Net Debt / EBITDA
12.23x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.239
Weak
WeakModerateStrong
Return on Invested Capital
11.52%
Weak
WeakModerateStrong
Cash Conversion Cycle
691.05 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for UMTAF.
View Financial Statements